September 2017 Issue of MMM

September 2017 Issue of MMM

Go Figure

Infographic | The leaders of the global hepatitis-C market

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Editor's Desk

Snubbing Intolerance: Frazier's Path Was Disengagement

Merck CEO Kenneth Frazier's exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a ...

At Work With

Otsuka's April Mitchell on leading versus managing

When you've figured out the difference, people will walk through fire for you, a mentor once told her.

Digital Edition

Read the September 2017 digital edition

Read the September 2017 issue in its entirety, including how marketing can save clinical trials.


Healthcare agencies intensify college recruiting tactics

They are using social media campaigns, apprentice programs, and hands-on internships to recruit young, innovative talent right out of school.

Investors put their money on point of care

Two recent cash infusions suggest investors are bullish on point-of-care advertising. Is the channel ready for its moment in the spotlight?

Experts say pharma's move to Snapchat is in the making

Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.

Can marketing techniques save clinical trials?

No crucial area in pharma is more desperately in need of a fix — or more stubbornly resistant to change.


Horizon CEO Tim Walbert knows patients because he is one

He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie's Humira, which he helped commercialize.

Upward Move

Astellas promotes two sales veterans to new roles

David Musselman and Lynn Gerber are now leading sales for the company's primary care and specialty products.

Neil Matheson leaves Huntsworth Health

The CEO of Huntsworth's biggest and fastest-growing unit Huntsworth Health, which includes Nitrogen and Tonic Life, has departed after eight years.

Lynn O'Connor Vos to leave ghg; Erin Byrne named CEO

O'Connor Vos has served as CEO of the WPP Health & Wellness agency since 1994.

Therapeutic Focus

Top 25 vaccine products in 2016, based on U.S. sales

Pfizer's Prevnar tops the list, according to data compiled by EvaluatePharma.

Why Sanofi's dengue fever vaccine fell short of expectations

Dengvaxia's post-launch plight reflects the difficulties of launching a vaccine. Is this a harbinger for future vaccine-marketing efforts?

In Focus

Biogen, Merck use predictive modeling to better negotiate value-based contracts

What's holding back value-based pricing deals from moving beyond the pilot phase?

Partner Forum

4 Ways Marketers Can Work With Advocacy Groups to Achieve Brand Objectives

As the influence of patient communities and advocacy groups grows, how can marketers work these organizations to achieve brand objectives?

Beltway Insider

Questions About Promotion Prompt Marketers to Develop Code of Ethics

That's why the Coalition for Healthcare Communication is focused on creating self-regulatory guidelines.


Want to Win Hispanic Patients? Get Personal

More than other patient groups, they want a deeper, ongoing relationship with caregivers.

Why Science Needs a Story

If scientific storytelling alone can impact health outcomes, then how can we apply that knowledge in practice?

Private View

Carling Communications' Sherri Wilkins on 6 MS ads that offer promise

While multiple sclerosis can take a marked toll on patients and families, the message of optimism in these ads has never been more profound.

Back Talk

Digital Healthcare: Is It For Real?

The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.